Delivery Order SPE2DR25D3303-SPE2DR26F62A2
- Not listed
- The Defense Logistics Agency awarded a $2,110.14 delivery order to AmerisourceBergen Drug Corp for VIVITROL 380 mg vial-diluents on December 3, 2025, with completion scheduled for December 4, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. The award is issued from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major pharmaceutical distributor and critical vendor for...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 5, 2025, for the supply of Vivitrol 380 mg vials with diluents, valued at $3,003.48. This is a firm fixed price delivery order with an ultimate completion date of November 6, 2025, and represents a non-set-aside competitive award. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $2,002.34 to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Vivitrol 380 mg vial-diluents. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of September 16, 2025, and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. Vivitrol is an extended-release naltrexone injection used in substance use disorder treatment, representing part of...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Vivitrol 380 mg vials with diluents, valued at $1,269.91. This firm fixed-price delivery order was competitively awarded without set-aside designation and is scheduled for completion by October 28, 2025. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania. This award represents a child order under AmerisourceBergen's substantial Indefinite Delivery...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $5,730.90 on October 27, 2025, for the supply of Vivitrol 380 mg vial-diluents. This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of October 28, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $2,002.34 to AmerisourceBergen Drug Corp for Vivitrol 380 mg vial with diluents. This contract, awarded on August 19, 2025, with an ultimate completion date of August 20, 2025, represents a firm fixed price delivery order with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Vivitrol is a medication used in the treatment of opioid and alcohol use...
- The Defense Logistics Agency awarded a delivery order contract valued at $20,349.56 to AmerisourceBergen Drug Corp for the supply of VIVITROL 380 MG vials and diluents. This non-set-aside award was issued on August 21, 2025, with an ultimate completion date of August 22, 2025, and will be performed at the contractor's location in Conshohocken, Pennsylvania. VIVITROL is a medication used in opioid addiction treatment, and the supply of this pharmaceutical product supports federal healthcare needs...
- The Defense Logistics Agency (DLA) awarded a $2,002.34 delivery order to AmerisourceBergen Drug Corp for VIVITROL 380 MG vial-diluents on June 18, 2025, with an ultimate completion date of June 20, 2025. This firm fixed price contract was competitively awarded with no set-aside designation and will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. VIVITROL is an extended-release injectable medication used primarily for opioid use disorder treatment, making...
- The Defense Logistics Agency awarded a $3,003.48 delivery order to AmerisourceBergen Drug Corp on October 22, 2025, for the supply of Vivitrol 380 mg vial-diluents. This is a firm fixed-price contract with an ultimate completion date of October 23, 2025, and represents a non-competitive, non-set-aside award. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $2,505.42 to AmerisourceBergen Drug Corp for Vivitrol 380 mg vial-diluents, with an ultimate completion date of November 17, 2025. This firm fixed-price delivery order, awarded on November 14, 2025, represents a non-set-aside competitive award. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- SPE2DR25D3303Indefinite Delivery Contract
- SPE2DR25D3303-SPE2DR26F62A2Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,110.14 to AmerisourceBergen Drug Corp for the supply of VIVITROL 380 mg vial-diluents. This is a firm fixed price, non-set-aside delivery order with an ultimate completion date of November 25, 2025, issued on November 24, 2025. The products will be delivered to AmerisourceBergen's location in Conshohocken, Pennsylvania. VIVITROL is an extended-release naltrexone formulation used in opioid use disorder treatment, representing a critical pharmaceutical commodity within the federal medical supply chain. This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 comprehensive pharmaceutical supply vehicle running through December 2026. The IDC enables the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, serving customers including the Defense Health Agency and U.S. Coast Guard. AmerisourceBergen's consistent competitive awards and substantial federal contract portfolio demonstrate its established capability as a major pharmaceutical distributor meeting federal procurement requirements for the Department of Defense medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.1k | 11/23/25 |